Displaying drugs 10401 - 10425 of 10844 in total
Varespladib
Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome.
Investigational
Matched Description: … Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive …
SRT-2104
SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.
Investigational
Matched Description: … SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular …
DTx-1252
DTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).
Investigational
Matched Description: … DTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease …
CLBS12
CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational
Matched Description: … GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of …
BBT-877
BBT-877 is an autotaxin enzyme inhibitor being investigated for the treatment of fibrotic diseases, such as idiopathic pulmonary fibrosis.
Investigational
Matched Description: … BBT-877 is an autotaxin enzyme inhibitor being investigated for the treatment of fibrotic diseases, such …
D-Aspartic Acid
The D-isomer of aspartic acid. [PubChem]
Experimental
Matched Description: … The D-isomer of aspartic acid. [PubChem] …
Malonaldehyde
Malonaldehyde is the dialdehyde of malonic acid.
Experimental
Matched Description: … Malonaldehyde is the dialdehyde of [malonic acid]. …
2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid
Metabolic product of biphenyl; from Pseudomonas putida.
Experimental
Matched Description: … Metabolic product of biphenyl; from Pseudomonas putida. …
Quinaprilat
The active metabolite of the prodrug quinapril.
Experimental
Matched Description: … The active metabolite of the prodrug [quinapril]. …
Zingerone
Zingerone is a pungent component of ginger.
Experimental
Matched Description: … Zingerone is a pungent component of ginger. …
Adrabetadex
Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1).
Investigational
Matched Description: … Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous …
Iofolastat I-123
Iofolastat I-123 is under investigation in clinical trial NCT00992745 (A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer).
Investigational
Matched Description: … 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer). ... Iofolastat I-123 is under investigation in clinical trial NCT00992745 (A Phase I Pilot Study Comparing …
TAK-243
TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia).
Investigational
Matched Iupac: … [(1R,2R,3S,4R)-2,3-dihydroxy-4-[(2-{3-[(trifluoromethyl)sulfanyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl …
Matched Description: … TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed …
Matched Description: … TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed …
NPI 32101
NPI 32101 possesses both anti-inflammatory and broad spectrum antimicrobial activities. This combination of pharmacological properties may have additional therapeutic uses beyond dermatology.
Investigational
Matched Description: … This combination of pharmacological properties may have additional therapeutic uses beyond dermatology …
Drostanolone
Drostanolone (also known as dromostanolone) is a potent synthetic androgenic anabolic steroid similar to testosterone. Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone therapy.
Illicit
Matched Iupac: … 3aS,3bR,5aS,8R,9aS,9bS,11aS)-1-hydroxy-8,9a,11a-trimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7- …
Matched Description: … Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone …
Matched Description: … Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone …
Lintuzumab satetraxetan AC-225
Lintuzumab actinium Ac-225 is under investigation in clinical trial NCT00672165 (Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies).
Investigational
Matched Description: … (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid ... Lintuzumab actinium Ac-225 is under investigation in clinical trial NCT00672165 (Targeted Atomic Nano-Generators …
Anagliptin
Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors.
Investigational
Matched Description: … Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus …
RAD-140
RAD140 is an investigational selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting and breast cancer.
Experimental
Investigational
Matched Description: … RAD140 is an investigational selective androgen receptor modulator (SARM) for the treatment of conditions …
Y-27632
Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.
Experimental
Matched Description: … Y-27632 is an inhibitor of Rho-associated protein kinase. …
DADLE
A delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate.
Experimental
Matched Description: … It can cause transient depression of mean arterial blood pressure and heart rate. …
Saracatinib
Saracatinib has been investigated for the treatment of Cancer, Osteosarcoma, Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer.
Investigational
Matched Iupac: … N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin- …
Matched Description: … Saracatinib has been investigated for the treatment of Cancer, Osteosarcoma, Ovarian Cancer, Fallopian …
Matched Description: … Saracatinib has been investigated for the treatment of Cancer, Osteosarcoma, Ovarian Cancer, Fallopian …
Sarpogrelate
Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic.
Investigational
Matched Description: … Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary …
Aloglutamol
Aloglutamol is an antacid salt of aluminium, gluconic acid, and tris. Proprietary names include Altris, Pyreses, Tasto and Sabro.
Experimental
Matched Description: … Aloglutamol is an antacid salt of aluminium, gluconic acid, and tris. …
Ligandrol
Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis.
Investigational
Matched Description: … Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions …
S64315
S64315 (MIK665) is an inhibitor of induced myeloid leukemia cell differentiation protein Myeloid cell leukemia 1 (Mcl-1).
Investigational
Matched Description: … S64315 (MIK665) is an inhibitor of induced myeloid leukemia cell differentiation protein Myeloid cell …
Displaying drugs 10401 - 10425 of 10844 in total